Location: Zurich, Switzerland
CIK: 0001595430 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $1.421B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 7,601,087 | $739M | 52.0% | $40.59 | +153.8% | COM | 76155X100 |
| TYRA | TYRA BIOSCIENCES INC | 4,055,861 | $155M | 10.9% | $12.94 | +133.8% | COM | 90240B106 |
| TNGX | TANGO THERAPEUTICS INC | 7,266,081 | $152M | 10.7% | $3.92 | +203.4% | COM | 87583X109 |
| ORIC | ORIC PHARMACEUTICALS INC | 7,162,637 | $90.75M | 6.4% | $8.21 | +31.1% | COM | 68622P109 |
| ALMS | ALUMIS INC | 3,540,998 | $78.01M | 5.5% | $8.64 | +181.6% | COM | 022307102 |
| RLAY | RELAY THERAPEUTICS INC | 5,526,506 | $54.99M | 3.9% | $5.07 | +63.7% | COM | 75943R102 |
| ZYME | ZYMEWORKS INC | 1,113,946 | $27.89M | 2.0% | $13.64 | +71.4% | COM | 98985Y108 |
| KYMR | KYMERA THERAPEUTICS INC | 278,896 | $23.23M | 1.6% | $34.43 | +125.3% | COM | 501575104 |
| CTMX | CYTOMX THERAPEUTICS INC. | 4,449,932 | $20.91M | 1.5% | $5.23 | 0.0% | COM | 23284F105 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,419,355 | $19.44M | 1.4% | $0.87 | +135.4% | COM | 21077P108 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,141,145 | $16.22M | 1.1% | $9.60 | +24.7% | COM | 230031106 |
| ENGN | ENGENE HOLDINGS INC | 2,324,943 | $15.83M | 1.1% | $8.15 | +18.5% | COM | 29286M105 |
| CRVS | CORVUS PHARMACEUTICALS INC | 450,000 | $6.583M | 0.5% | $16.29 | 0.0% | COM | 221015100 |
| ARVN | ARVINAS INC | 539,394 | $5.718M | 0.4% | $15.67 | -19.8% | COM | 04335A105 |
| SLN | SILENCE THERAPEUTICS PLC | 952,400 | $5.019M | 0.4% | $2.82 | — | ADS | 82686Q101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 304,237 | $5.005M | 0.4% | $14.07 | +46.9% | COM | 61225M102 |
| SPRY | ARS PHARMACEUTICALS INC | 610,703 | $4.904M | 0.3% | $12.03 | -14.9% | COM | 82835W108 |